Noxxon Pharma develops biostable aptamers and substances based on mirror image nucleic acids.
Noxxon Pharma has raised €35M across 2 funding rounds, most recently a round in Oct 2010. Based in Berlin, Germany; founded 2007; active in Media. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2010-10-01 | Other | €2.0M | — | View deal → |
| 2010-05-01 | Other | €33M | — | View deal → |
